Venclyxto (venetoclax) film-coated tablets- all strengths

The SPC has been updated to reflect licence extension covering use in combination with a hypomethylating agent for the treatment of adult patients with newly diagnosed acute myeloid who are ineligible for intensive chemotherapy.

Source:

electronic Medicines compendium